2ZE-85437-91533
4 vaccinations
3 coded responses
47 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 209 / MD
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QL2-74148-64616
Child or adolescent in my care · Female · 2023-04-01
Timeline
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-01-15
Registered in v-safe
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
-
2021-01-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-19
- 2021-01-21
-
2021-01-28
Survey response — day 14, dose 1MedDRA: Lymphadenopathy, Oropharyngeal pain, Renal pain — Feeling: GoodFree text: Mild sore throat, mild kidney pain, and mild adenopathy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
- 2021-05-04
-
2021-08-03
Survey response — 6 months, dose 2MedDRA: Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Upper respiratory infectionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-03
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-11-20
-
2022-02-02
Survey response — 12 months, dose 2MedDRA: COVID-19, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I had COVID in August 2021. Also, I am currently 16 weeks pregnant.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-02
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-02
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-02-04
-
2022-02-05
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-02-06
- 2022-02-07
- 2022-02-08
- 2022-02-09
- 2022-02-10
- 2022-02-11
- 2022-02-14
- 2022-02-19
- 2022-03-05
- 2022-03-12
- 2022-03-19
- 2022-05-07
- 2022-08-06
- 2023-02-05
-
2023-03-31
Dose 4 — Pfizer-BioNTech
- 2023-04-01
- 2023-04-03
- 2023-04-04
- 2023-04-05
- 2023-04-06
- 2023-04-07
- 2023-04-23
- 2023-04-28
- 2023-05-05
- 2023-05-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2022-02-05 | Pfizer-BioNTech | Flu |
| 4 | 2023-03-31 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-03 | Successful 2022-02-02 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-02-02 | Unsuccessful |
Free text
Release 3 — day 14, dose 1
Symptoms: Mild sore throat, mild kidney pain, and mild adenopathy.
Release 9 — 6 months, dose 2
Symptoms: Upper respiratory infection
Release 11 — 12 months, dose 2
Symptoms: I had COVID in August 2021. Also, I am currently 16 weeks pregnant.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Renal pain | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release